How Long Until Bemotrizinol Is in Drugstore Sunscreens?
From launch to mass-market availability.
The FDA approved bemotrizinol (Parsol Shield) on June 9, 2026 — the first new US sunscreen active since the 1990s — but reformulating, testing and retail rollout typically take brands a year or more before products reach drugstore shelves.
Industry watchers expect bemotrizinol to appear first in premium launches before it filters down into mass-market drugstore sunscreens over the following seasons.
Questions we get a lot
When did the FDA approve bemotrizinol?
The FDA approved bemotrizinol (trade name Parsol Shield; also sold as Tinosorb S) on June 9, 2026, for adults and children 6 months and older at up to 6%. It is the first new active added to the US OTC sunscreen monograph since the 1990s.
How long until bemotrizinol reaches drugstore sunscreens?
Approval is just the start: brands still have to reformulate, stability- and SPF-test, manufacture and distribute. Expect early premium launches relatively quickly, with broad, affordable drugstore availability more likely to build over the following year or two as supply and pricing settle.
What is bemotrizinol and why is it worth waiting for?
Bemotrizinol is a broad-spectrum UVA+UVB filter that is highly photostable and cosmetically elegant, with no white cast. Its arrival gives US formulators a modern filter long available in Europe and Asia, which is why people are eager to see it in everyday drugstore products.
r/AsianBeauty: 'Now that bemotrizinol is FDA-approved, when will it actually show up in US drugstore sunscreens?'
